Skip to main content

Advertisement

Log in

Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The type 2 serotonin (5-HT2) receptor subfamily is known to couple to phosphoinositide hydrolysis (PI) and the subsequent mobilization of intracellular Ca2+, as well as the release of arachidonic acid (AA). Less is known of 5-HT2-mediated activation of the mitogen-activated protein kinase (MAPK) or extracellular signal-regulated kinase (ERK1/2) signaling. The present study measured the relative efficacies and potencies of 5-HT agonists to activate ERK2 in non-neuronal cells expressing recombinant human 5-HT2A, 5-HT2B, and 5-HT2C(ISV) receptors. 5-HT agonists stimulated ERK2 activity via all three 5-HT2 subtypes. There were no meaningful differences in the potencies or relative efficacies of these agonists to affect ERK2 activity vs. PI accumulation or Ca2+ mobilization, suggesting that these pathways may be sequentially linked. Indeed, ERK2 activity was very sensitive to PKC inhibition and calcium chelation and insensitive to tyrosine kinase and PI-3-kinase inhibition. 5-HT2 receptors efficiently couple to MAPK activation via sequential PI hydrolysis, and Ca2+ mobilization. This profile differs from reports of “agonist-directed trafficking of receptor stimulus” between PI/Ca2+ and AA pathways activated by 5-HT2 receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Banes A, Florian JA, Watts SW (1999) Mechanisms of 5-hydroxytryptamine2A receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther 291:1179–1187

    PubMed  CAS  Google Scholar 

  • Brown P, Gerfen CR (2006) Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway. J Comp Neurol 498:415–30

    Article  PubMed  CAS  Google Scholar 

  • Baxter G, Kennet G, Blaney F, Blackburn T (1995) 5-HT2 receptor subtypes: a family re-united. Trends Pharmacol Sci 16:105–109

    Article  PubMed  CAS  Google Scholar 

  • Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, Clarke WP (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94–104

    PubMed  CAS  Google Scholar 

  • Berg KA, Cropper JD, Niswender CM, Sanders-Bush E, Emeson RB, Clarke WP (2001) RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol 134:386–392

    Article  PubMed  CAS  Google Scholar 

  • Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, Chan HW, Eglen RM (1995) The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol 115:622–628

    PubMed  CAS  Google Scholar 

  • Chang M, Zhang LS, Tam JP, Sanders-Bush E (2000) Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides: endogenous 5-HT2C receptors in choroid plexus epithelial cells. J Biol Chem 275:7021–7029

    Article  PubMed  CAS  Google Scholar 

  • Chengalvala M, Kostek B, Frail DE (1999) A multi-well filtration assay for quantification of inositol phosphates in biological samples. J Biochem Biophys Methods 38:163–70

    Article  PubMed  CAS  Google Scholar 

  • Conn PJ, Sanders-Bush E (1984) Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex. Neuropharmacology 23(8):993–996

    Article  PubMed  CAS  Google Scholar 

  • Cussac D, Newman-Tancredi A, Duqueyroix D, Pasteau V, Millan MJ (2002) Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine (2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. Mol Pharmacol 62:578–589

    Article  PubMed  CAS  Google Scholar 

  • Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95–105

    Article  PubMed  CAS  Google Scholar 

  • Egan C, Grinde E, Dupre A, Roth BL, Hake M, Teitler M, Herrick-Davis K (2000) Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors. Synapse 235:144–50

    Article  Google Scholar 

  • Felder CC, Kanterman RY, Ma AL, Axelrod J (1990) Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc Natl Acad Sci U S A 87:2187–2191

    Article  PubMed  CAS  Google Scholar 

  • Fitzgerald LW, Conklin DS, Krause CM, Marshall AP, Patterson JP, Tran DP, Iyer G, Kostich WA, Largent BL, Hartig PR (1999a) High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action. J Neurochem 72:2127–2134

    Article  PubMed  CAS  Google Scholar 

  • Fitzgerald LW, Iyer G, Conklin DS, Krause CM, Marshall A, Patterson JP, Tran DP, Jonak GJ, Hartig PR (1999b) Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21:82S–90S

    PubMed  CAS  Google Scholar 

  • Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun J-H, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW (2000) Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Mol Pharmacol 57:75–81

    PubMed  CAS  Google Scholar 

  • Florian JA, Watts SW (1998) Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction. J Pharmacol Exp Ther 284(1):346–355

    PubMed  CAS  Google Scholar 

  • Galandrin S, Oligny-Longpré G, Bouvier M (2007) The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 28:423–430

    Article  PubMed  CAS  Google Scholar 

  • Gay EA, Urban JD, Nichols DE, Oxford GS, Mailman RB (2004) Functional selectivity of D-2 receptor ligands in a Chinese hamster ovary hD(2L) cell line: evidence for induction of ligand-specific receptor states. Mol Pharmacol 66:97–105

    Article  PubMed  CAS  Google Scholar 

  • Girault JA, Valjent E, Caboche J, Hervé D (2007) ERK2: a logical AND gate critical for drug-induced plasticity. Curr Opin Pharmacol 7:77–85

    Article  PubMed  CAS  Google Scholar 

  • Greene EL, Houghton O, Collinsworth G, Garnovskaya MN, Nagai T, Sajjad T, Bheemanathini V, Grewal JS, Paul RV, Raymond JR (2000) 5-HT2A receptors stimulate mitogen-activated protein kinase via H2O2 generation in rat renal mesangial cells. Am J Physiol Renal Physiol 278:F650–F658

    PubMed  CAS  Google Scholar 

  • Hershenson MB, Chao T-SO, Abe MK, Gomes I, Kelleher MD, Sloway J, Rosner MR (1995) Histamine antagonizes serotonin and growth factor induced mitogen-activated protein kinase activation in bovine tracheal smooth muscle cells. J Biol Chem 270:19908–19913

    Article  PubMed  CAS  Google Scholar 

  • Jerman JC, Brough SJ, Gager T, Wood M, Coldwell MC, Smart D, Middlemiss DN (2001) Pharmacological characterization of human 5-HT2 receptor subtypes. Eur J Pharmacol 414:23–30

    Article  PubMed  CAS  Google Scholar 

  • Kenakin T (2007a) Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28:407–415

    Article  CAS  Google Scholar 

  • Kenakin T (2007b) Functional selectivity through protean and biased agonism: who steers the ship? Mol Pharmacol 72:1393–1401

    Article  CAS  Google Scholar 

  • Launay JM, Guillaume B, Bondoux D, Callebert J, Choi DS, Loric S, Maroteaux L (1996) Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J Biol Chem 271:3141–3147

    Article  PubMed  CAS  Google Scholar 

  • Leysen JE (2004) 5-HT2 Receptors. Curr Drug Targets CNS Neurol Disord 3:11–26

    Article  PubMed  CAS  Google Scholar 

  • Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP (2007) Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Pharmacol Exp Ther 321:1054–1061

    Article  PubMed  CAS  Google Scholar 

  • Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B, and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol 128:13–20

    Article  PubMed  CAS  Google Scholar 

  • Pierce KL, Luttrell LM, Lefkowitz LJ (2001) New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532–1539

    Article  PubMed  CAS  Google Scholar 

  • Quinn JC, Johnson-Farley NN, Yoon J, Cowen DS (2002) Activation of extracellular-regulated kinase by 5-hydroxytryptamine2A receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases. J Pharmacol Exp Ther 303:746–752

    Article  PubMed  CAS  Google Scholar 

  • Roth BL, Nakaki T, Chuang DM, Costa E (1984) Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover. Neuropharmacology 23(10):1223–1225

    Article  PubMed  CAS  Google Scholar 

  • Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka BK, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton P et al (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1–13

    Article  PubMed  CAS  Google Scholar 

  • Wainscott DB, Sasso DA, Kursar JD, Baez M, Lucaites VL, Nelson DL (1998) [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor. Naunyn-Schmiedeberg’s Arch Pharmacol 357:17–24

    Article  CAS  Google Scholar 

  • Werry TD, Gregory KJ, Sexton PM, Christopoulos A (2005) Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2. J Neurochem 93:1603–1615

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lawrence W. Fitzgerald.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knauer, C.S., Campbell, J.E., Chio, C.L. et al. Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors. Naunyn-Schmied Arch Pharmacol 379, 461–471 (2009). https://doi.org/10.1007/s00210-008-0378-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-008-0378-4

Keywords

Navigation